🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yingjie Qiu

The University of Texas Southwestern Medical Center

ORCID: 0009-0009-9429-2131
MedicineMathematicsDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Relationships between reproductive hormones and maternal pregnancy physiology in women conceiving with or without in vitro fertilization”.

Relationships between reproductive hormones and maternal pregnancy physiology in women conceiving with or without in vitro fertilization

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology(2021)10.1152/ajpregu.00174.2020
N/A
0.662DataRank · unranked
13 citations

Shèdy Taher, Yueh‐Yun Chi, Yingjie Qiu, Mingyue Li, Melissa Lingis +5 more

Modified isotonic regression based phase I/II clinical trial design identifying optimal biological dose

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107139
N/A
0DataRank · unranked
8 citations

Yi Zhao, Hao Liu, Sha Cao, Chi Zhang, Yong Zang +1 more

Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies

Clinical Trials(2024)10.1177/17407745231220661
N/A
0DataRank · unranked
16 citations

Beibei Guo, Yingjie Qiu, Hao Liu, Mateusz Opyrchal, Xiongbin Lu +1 more

A randomized Bayesian phase I-II dose optimization design for combination cancer therapies with progression-free survival end point

BMC Medical Research Methodology(2025)10.1186/s12874-025-02665-4
N/A
0DataRank · unranked
2 citations

Mingyue Li, Yingjie Qiu

A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials

Statistical Methods in Medical Research(2025)10.1177/09622802251374290
N/A
0DataRank · unranked
2 citations

Mingyue Li, Yingjie Qiu

UNITED: A Unified Transparent and Efficient Phase I/II Trial Design for Dose Optimization Accounting for Ordinal Graded, Continuous and Mixed Toxicity and Efficacy Endpoints

Statistics in Medicine(2025)10.1002/sim.70098
N/A
0DataRank · unranked
3 citations

Zhonglong Guo, Yingjie Qiu, Mingyue Li

A Generalized Model-Free Framework for Dose Optimization in Multiple-Dose Randomized Early-Phase Clinical Trials

Statistics in Biosciences(2025)10.1007/s12561-025-09481-w
N/A
0DataRank · unranked
0 citations

Fang Liu, Qing Zhao, Yixin Ren, Heng Zhou, Yingjie Qiu

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit

Pharmaceutical Statistics(2025)10.1002/pst.70049
N/A
0DataRank · unranked
0 citations

Yingjie Qiu, Yi Zhao, Isabella Wan, Lang Li, Suyu Liu +2 more